Related references
Note: Only part of the references are listed.Quantitative Meta-analysis Identifies Brain Regions Activated During Rectal Distension in Irritable Bowel Syndrome
Kirsten Tillisch et al.
GASTROENTEROLOGY (2011)
Inflammation and Microflora
Mark Pimentel et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2011)
Potential Biomarkers
Robin C. Spiller
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2011)
Emerging Pharmacological Therapies for the Irritable Bowel Syndrome
Monthira Maneerattanaporn et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2011)
Traditional Thoughts on the Pathophysiology of Irritable Bowel Syndrome
William L. Hasler
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2011)
Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome
Angele P. M. Kerckhoffs et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Antibiotic Therapy for the Irritable Bowel Syndrome.
Jan Tack
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.
Mark Pimentel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Randomized, Double-Blind, Placebo-Controlled Trial of St John's Wort for Treating Irritable Bowel Syndrome
Yuri A. Saito et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Investigations on 5-HT4 Receptor Expression and Effects of Tegaserod on Human Platelet Aggregation In Vitro
Victor L. Serebruany et al.
AMERICAN JOURNAL OF THERAPEUTICS (2010)
Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia
Alexander C. Ford et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Effect of Meal Ingestion on Ileocolonic and Colonic Transit in Health and Irritable Bowel Syndrome
Annemie Deiteren et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
The Effect of Enteric-Coated, Delayed-Release Peppermint Oil on Irritable Bowel Syndrome
Shahin Merat et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis
Archana S. Rao et al.
GASTROENTEROLOGY (2010)
Efficacy of Linaclotide for Patients With Chronic Constipation
Anthony J. Lembo et al.
GASTROENTEROLOGY (2010)
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
P. Moayyedi et al.
GUT (2010)
Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life
Makiko Kaji et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Asian consensus on irritable bowel syndrome
Kok-Ann Gwee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health-care practitioners
Oliver Grundmann et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Pathogenesis of IBs: role of inflammation, immunity and neuroimmune interactions
Lena Ohman et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort
N. Manabe et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Central and peripheral hypersensitivity in the irritable bowel syndrome
Qiqi Zhou et al.
PAIN (2010)
A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome
Mahnaz Darvish-Damavandi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Ian M. Carroll et al.
GUT PATHOGENS (2010)
Asian Motility Studies in Irritable Bowel Syndrome
Oh Young Lee
Journal of Neurogastroenterology and Motility (2010)
Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
Anthony Lembo et al.
GASTROENTEROLOGY (2010)
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies
D. A. Drossman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
A Treatment Trial of Acupuncture in IBS Patients
Anthony J. Lembo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
Darren M. Brenner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?
Seth Sweetser et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis
Alexander C. Ford et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Prevalence and Risk Factors for Overlaps between Gastroesophageal Reflux Disease, Dyspepsia, and Irritable Bowel Syndrome: A Population-Based Study
Soon Young Lee et al.
DIGESTION (2009)
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
A. C. Ford et al.
GUT (2009)
Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study
Brian P. Brennan et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Epidemiology of irritable bowel syndrome in Asia: Something old, something new, something borrowed
Kok-Ann Gwee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Post-infectious irritable bowel syndrome
Marroon Thabane et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial
C. J. Bijkerk et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation
J. F. Johanson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome
A. W. Mangel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease
B. Nojkov et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation:: A randomized controlled trial
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Small intestinal bacterial overgrowth recurrence after antibiotic therapy
Ernesto C. Lauritano et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Complementary and alternative medicine use and cost in functional bowel disorders: A six month prospective study in a large HMO
Miranda Al van Tilburg et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2008)
Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients
Allen W. Mangel et al.
DIGESTION (2008)
A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome
K. Matsueda et al.
DIGESTION (2008)
Novel pharmacology:: asimadoline, a κ-opioid agonist, and visceral sensation
M. Camilleri
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome
S. M. Leventer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis
Alexander C. Ford et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects
Anna Kassinen et al.
GASTROENTEROLOGY (2007)
Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome
C. L. Frissora et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Irritable bowel syndrome in persons who acquired trichinellosis
Mujde Soyturk et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen
John K. Marshall et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease
Durk R. de Vries et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome
L. Ohman et al.
DIGESTIVE AND LIVER DISEASE (2007)
The serotonin signaling system: From basic understanding to drug development-for functional GI disorders
Michael D. Gershon et al.
GASTROENTEROLOGY (2007)
Studying the overlap between IBS and GERD: A systematic review of the literature
Igor Nastaskin et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
The effect of a nonabsorbed oral antibiotic (Rifaximin) on the symptoms of the irritable bowel syndrome - A randomized trial
Mark Pimentel et al.
ANNALS OF INTERNAL MEDICINE (2006)
Postinfectious irritable bowel syndrome - A meta-analysis
Heather A. Halvorson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
Peter J. Whorwell et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome:: A systematic review
Zhaoxiang Bian et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2006)
Acupuncture treatment in irritable bowel syndrome
A Schneider et al.
GUT (2006)
Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: Systematic review of clinical trials and post-marketing surveillance data
Lin Chang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome
T Nozu et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome
V Khoshoo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome
W Atkinson et al.
GASTROENTEROLOGY (2006)
Effect of tegaserod on gut transit in male and female subjects
L Degen et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
Role of tumor necrosis factor-α and interleukin-10 gene polymorphisms in irritable bowel syndrome
PPJ van der Veek et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Acupuncture for irritable bowel syndrome: A blinded placebo-controlled trial
Alastair Forbes et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Genetics and genotypes in irritable bowel syndrome: Implications for diagnosis and treatment
MI Park et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2005)
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
APS Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Bowel habit subtypes and temporal patterns in irritable bowel syndrome: Systematic review
M Guilera et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Mechanisms of pulmonary vascular complications of liver disease - Hepatopulmonary syndrome
MB Fallon
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
SP Dunlop et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Lactobacillus and Bifidobacterium in irritable bowel syndrome:: Symptom responses and relationship to cytokine profiles
L O'Mahony et al.
GASTROENTEROLOGY (2005)
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR
E Malinen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS
L Chang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Inappropriate medication prescribing for elderly ambulatory care patients
MR Goulding
ARCHIVES OF INTERNAL MEDICINE (2004)
A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome
H Nyhlin et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Small intestinal bacterial overgrowth - A framework for understanding irritable bowel syndrome
HC Lin
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Meta-analysis: the treatment of irritable bowel syndrome
D Lesbros-Pantoflickova et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Review article: the safety profile of tegaserod
P Schoenfeld
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome
WD Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
J Kellow et al.
GUT (2003)
Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome
LA Houghton et al.
GUT (2003)
A systematic review of alternative therapies in the irritable bowel syndrome
JA Spanier et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?
WM Gonsalkorale et al.
GUT (2003)
A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation
J Novick et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome
G Tougas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Health-related quality of life among persons with irritable bowel syndrome: a systematic review
HB El-Serag et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
SA Müller-Lissner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome
M Camilleri et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome
T Poynard et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Acupuncture treatment for irritable bowel syndrome - A double-blind controlled study
Z Fireman et al.
DIGESTION (2001)
Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials
J Jailwala et al.
ANNALS OF INTERNAL MEDICINE (2000)
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
M Camilleri et al.
LANCET (2000)
The impact of irritable bowel syndrome on health-related quality of life
IM Gralnek et al.
GASTROENTEROLOGY (2000)
Share Paper
